1. Pink Sheet
  2. >>Geography
  3. >>North America
  4. >>United States

FDA Making A Generic Case For Continuous Manufacturing

 
• By Derrick Gingery

The industry that makes the vast majority of drugs has yet to embrace the new production approach, but FDA hopes that platform standardization will make it more compelling.

FDA is hoping a standardized continuous manufacturing platform will entice the generic industry to embrace the new technology.

Brand companies now are becoming interested in the process that aims to replace the conventional batch manufacturing system. A continuous manufacturing operation does not have scale-up issues like batch processing...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America